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nors	prompted	us	 to	examine	 the	 impact	of	donor	 type	on	 the	 incidence	of	ureteric	
























urinary	 infections.6,7	The	 stented	 extravesical	 anastomosis	 has	 now	
become	the	standard	technique	for	ureteric	 implantation	as	 it	 is	as-
sociated	with	a	relatively	low	complication	rate.8-10	When	performing	







use	of	 kidneys	 from	donation	after	 circulatory	death	 (DCD)	donors.	
It	is	widely	thought	that	ischemic	damage	of	the	donor	ureter	due	to	


















A	 single-	center,	 retrospective,	 observational,	 cohort	 study	 was	 per-
formed	to	examine	the	impact	of	donor	type	(DCD,	DBD,	LD)	on	the	inci-
dence	of	UC	after	kidney	transplantation.	Data	on	all	kidney	transplants	
performed	 at	 the	 Cambridge	 Transplant	 Centre	 were	 prospectively	




December	31,	2014).	Dual	kidney	 transplants	and	 recipients	of	 com-
bined	and	multivisceral	transplants	were	excluded	from	the	analysis.	All	
DCD	kidneys	were	procured	from	controlled,	Maastricht	category	3	and	





















suspected	by	 the	presence	of	hydronephrosis	of	 the	 transplant	 kid-
ney	 on	 ultrasound	 examination	 and	 confirmed	 in	 all	 cases	 by	 a	 ne-
phrostogram	 after	 radiologically	 guided	 insertion	 of	 a	 percutaneous	
	nephrostomy	 tube.	A	 urine	 leak	 from	 the	 vesicoureteric	 anastomo-
sis	was	defined	as	the	 leak	of	urine	from	the	abdominal	wound,	the	
presence	of	a	perinephric	urine	collection	 (identified	on	 radiological	
imaging	 and	 confirmed	 by	 biochemical	 analysis	 of	 the	 aspirate),	 or	
the	 presence	 of	 a	 leak	 identified	 by	 an	 antegrade	 nephrostogram.	
Where	 surgical	 intervention	 was	 deemed	 necessary,	 it	 comprised	
re-	implantation	of	 the	donor	ureter	onto	 the	bladder	or	 creation	of	
a	donor	ureter	to	native	ureter	ureteroureterostomy	or	creation	of	a	
donor	 pelvis	 to	 native	ureter	 pyeloureterostomy.	All	 ureteric	 recon-
structions	were	performed	over	a	double	pigtail	ureteric	stent,	which	
was	removed	after	approximately	6	weeks.
Extended	 criteria	 donors	 (ECD)	were	 defined	 as	 those	 ≥60	years	
or	 those	 aged	50-	59	years	with	 two	of	 the	 following	 three	 features:	
hypertension;	terminal	serum	creatinine	>115	mmol/L;	or	death	from	
cerebrovascular	accident.14	Delayed	graft	function	was	defined	as	the	








Data	 are	 summarized	 as	 mean	 (SD)	 or	 median	 (interquartile	 range)	
as	 appropriate.	 For	 comparison	 of	 fixed	 covariates,	 Fisher’s	 exact,	









proportional	hazards	 regression	analysis.	 Fixed	 covariates	 that	were	





and	one	kidney	 transplant	 recipient	 immediately	after	every	case	of	





































UCs (n=37) No UCs (n=1035)
Log- rank test 
on time to UCs
Transplant	type,	n	(%)
Kidney 34	(92) 911	(88) 0.43
SPK 3	(8) 124	(12)
Male	donors,	n	(%) 18	(49) 548	(53) 0.60
Male	recipients,	n	(%) 29	(78) 643	(62) 0.05
Donor	age	(y),	mean	(SD;	range) 51	(16,	14-	78) 49	(16,	5-	82) 0.43a
Recipient	age	(y),	mean	(SD;	range) 50	(15,	22-	72) 49	(13,	17-	75) 0.42a
Donor	extended	criteria	status,	n	(%)











Renal	artery	multiplicity,	n	(%) 9	(24) 289	(28) 0.61
HLA	mismatch	levelb










Re-	transplant,	n	(%) 5	(14) 110	(11) 0.57
Cold	ischemic	time,	mean	(SD;	range,	in	h)c 10.6	(5.9,	1.2-	22.2) 11.7	(6.2,	1-	34.9) 0.49
(Continues)
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recipient	of	DCD	kidneys	(4.5%)	than	for	those	who	received	LD	kid-
neys	(3.7%)	and	DBD	kidneys	(1.6%).	In	univariate	analysis	(Figure	1	
and	 Table	3),	 recipients	 of	 DCD	 kidneys	 had	 a	 significantly	 greater	
risk	of	developing	UCs	compared	to	recipients	of	DBD	kidneys	(HR:	
2.77,	 95%	CI:	 1.05-	7.31,	P=.04),	whereas	 the	 risk	 of	UCs	was	 sim-
ilar	 for	 recipients	of	LD	and	DBD	kidneys	 (HR:	0.46,	95%	CI:	0.16-	







Similarly,	 there	was	no	association	between	UCs	and	 transplant	 re-
cipient	 characteristics	 (age,	 gender,	 and	 sensitization	 to	 HLA)	 or	









N Total (%) Stenosis (%) Leak (%)
LD 273 10	(3.7) 8	(2.9) 2	(0.7)
DCD 494 22	(4.5) 16	(3.2) 6	(1.2)
DBD 305 5	(1.6) 4	(1.3) 1	(0.3)
Total 1072 37	(3.5) 28	(2.6) 9	(0.8)
LD,	 live	donors;	DCD,	donors	after	circulatory	death;	DBD,	donors	after	
brain	death.





UCs (n=37) No UCs (n=1035)
Log- rank test 
on time to UCs
Prolonged	cold	ischemic	timed,	n	(%) 5	(14) 137	(14) 0.98
Warm	ischemic	time,	mean	(SD;	range	in	min)e 7.9	(5.1,	1-	20) 9.2	(5.4,	1-	50) 0.29
Delayed	graft	functionf,	n	(%) 19	(51) 393	(38) 0.10
Primary	nonfunctionf,	n	(%) 1	(3) 26	(4) 0.94
Urinary	tract	infectiong,	n	(%) 16	(43) 27	(36) 0.55
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95%	CI:	0.18-	1.44,	P=.20).	We	have	also	examined	whether	the	warm	
ischemic	insult	integral	to	DCD	organ	procurement	might	contribute	




1-	20	minutes)	 and	without	UCs	 (mean:	9.2	minutes,	 SD:	5.4,	 range:	
1-	50	minutes).









sion	analysis	 to	determine	 risk	 factors	 for	 the	development	of	UCs.	
As	shown	in	Table	3,	DCD	kidney	transplantation	was	not	associated	
with	a	significant	 increase	 in	 the	risk	of	UCs;	 this	was	also	the	case	
when	the	analysis	was	repeated,	excluding	cases	of	urinary	leak	(DCD	
vs	DBD	HR:	2.33,	95%	CI:	0.77-	7.03,	P=.13).	There	was	a	trend	to-
















of	DCD	kidneys	and	 lowest	 in	 recipients	of	DBD	kidneys,	 although	


















prostatic	hypertrophy	might	be	a	contributing	 factor.	 In	 the	present	
series,	as	 in	our	earlier	series,7	 the	majority	of	UCs	were	 treated	by	
surgical	intervention.	Surgery	was	successful	in	all	but	one	patient	who	
required	 an	 additional	 surgical	 procedure	 to	 be	 performed.	 Others	
have	reported	on	the	effective	treatment	of	ureteric	stenosis	by	en-
dourological	 approaches,	 most	 notably	 ureteric	 dilatation,	 although	
these	approaches	are	associated	with	 lower	success	rates	and	more	
complications	 than	open	 surgical	 intervention.17	 It	was	notable	 that	
no	recipient	deaths	or	graft	failures	occurred	in	the	present	series	as	a	
direct	result	of	UCs.
Kidneys	 from	 DCD	 donors	 are	 increasingly	 used	 for	 transplan-






cipients	 of	 kidneys	 from	DBD	donors.18,19	Moreover,	 as	 highlighted	
in	 the	 present	 study,	 kidneys	 from	DCD	donors	 have	 a	 numerically	
higher	incidence	of	UCs	compared	to	DBD	kidneys,	but	the	incidence	
of	UCs	is	<5%	and	is	not	statistically	significant	when	other	variables	
are	 taken	 into	 account.	 Notably,	we	 found	 no	 association	 between	
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It	 is	 important	 to	 acknowledge	 some	 limitations	 of	 the	 present	







design,	the	present	study	 is	one	of	the	 largest	of	 its	kind	to	date,	 in	
which	DCD	transplants	comprised	almost	half	of	the	entire	cohort.	It	














script.	 JAB:	Carried	out	 research	design,	 analysis	 and	 interpretation	
of	data,	and	drafting	of	manuscript.	VK:	Carried	out	research	design,	
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